Archive:Past Webinars

Folate Metabolism, Mitochondrial Disease and Autism

DESCRIPTION

Free certificates of participation are available upon successful completion of a brief knowledge quiz at: https://www.classmarker.com/online-test/start/?quiz=yqt58b6db9137142


Published: 03/01/2017

Richard Frye Richard Frye, M.D., Ph.D.

Richard Frye, M.D., Ph.D. is the Director of Autism Research and Associate Professor of Pediatrics at The University of Arkansas for Medical Sciences. He specializes in pediatric neurology disorders, including learning disabilities and dyslexia, autism and developmental delay, speech and language delay, attention deficit, tics and Tourette’s syndrome, sleep disorders, and epileptic encephalopathy. Dr. Frye is board certified in General Pediatrics and in Neurology with special competency in Child Neurology. He has also completed Fellowships in Behavioral Neurology and Psychology. Dr. Frye has been funded by the National Institutes of Health to study brain reorganization in individuals with neurodevelopmental disorders and currently has grants to study mitochondrial disease in autism and the metabolic effects of tetrahydrobiopterin treatment in children with neurodevelopmental disorders.



ARI does not provide medical advice, diagnosis, or treatment.
ARI is a 501(c)(3) organization, Federal ID #95-2548452

Autism Research Institute
4182 Adams Avenue
San Diego, CA 92116